title: Canada welcomes a novel class of oral glucose-lowering drugs for people with type 2 diabetes.
authors.affiliation: Canadian Journal of Diabetes. Electronic address: cjd@diabetes.ca.
authors.forename: David C W
authors.initials: DC
authors.lastname: Lau
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D002170:Canada; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018450:Disease Progression; D006442:Glycated Hemoglobin / Q000187:drug effects*; D017408:Guidelines as Topic; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000172:deficiency*; D007333:Insulin Resistance / Q000502:physiology*
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin